Maintenance of Response to Risankizumab in Patients With Psoriatic Arthritis: A 3-Year Analysis of the KEEPsAKE 1 and 2 Trials. J of Skin 2023, 7 (6), s249. https://doi.org/10.25251/skin.7.supp.249.